CIK 0001699382 · Non-accelerated filer<br>Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463218129
- Phone
- (609) 642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-05 | Stelzer Laurie Director | Grant or award · Stock Option (right to buy) | +33,500 | 33,500 | ||
| 2025-06-05 | LEVINE ARNOLD J Director | Grant or award · Stock Option (right to buy) | +33,500 | 33,500 | ||
| 2025-06-05 | Heyman Richard A. Director | Grant or award · Stock Option (right to buy) | +33,500 | 33,500 | ||
| 2025-06-05 | Gallagher Carol Giltner Director | Grant or award · Stock Option (right to buy) | +33,500 | 33,500 | ||
| 2025-06-05 | Gallagher Carol Giltner Director | Gift · Stock Option (right to buy) | −33,500 | 0 | ||
| 2025-06-05 | Gallagher Carol Giltner Director | Gift · Stock Option (right to buy) | +33,500 | 33,500 | ||
| 2025-06-05 | FLOWERS KIRSTEN Director | Grant or award · Stock Option (right to buy) | +33,500 | 33,500 | ||
| 2025-06-05 | BAUM CHARLES M Director | Grant or award · Stock Option (right to buy) | +33,500 | 33,500 | ||
| 2025-03-03 | Carulli Michael Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +265,000 | 265,000 | ||
| 2025-03-03 | Jalota Deepika Chief Development Officer | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2025-03-03 | Mack David Henry President and CEO | Grant or award · Employee Stock Option (right to buy) | +800,000 | 800,000 | ||
| 2025-01-03 | Mack David Henry President and CEO | Option exercise | +17,709 | $0.53 | $9K | 551,919 |
| 2025-01-03 | Mack David Henry President and CEO | Option exercise · Employee Stock Option (right to buy) | −17,709 | 0 | ||
| 2024-12-03 | Mack David Henry President and CEO | Option exercise | +91,750 | $0.53 | $49K | 534,210 |
| 2024-12-03 | Mack David Henry President and CEO | Option exercise · Employee Stock Option (right to buy) | −91,750 | 17,709 | ||
| 2024-09-11 | Jalota Deepika Chief Development Officer | Sale | −7,218 | $1.50 | $11K | 118,283 |
| 2024-09-11 | Carulli Michael Chief Financial Officer | Sale | −2,891 | $1.50 | $4K | 88,395 |
| 2024-08-13 | Jalota Deepika Chief Development Officer | Returned to the company · Employee Stock Option (right to buy) | −22,674 | 0 | ||
| 2024-08-13 | Jalota Deepika Chief Development Officer | Returned to the company · Employee Stock Option (right to buy) | −68,100 | 0 | ||
| 2024-08-13 | Jalota Deepika Chief Development Officer | Grant or award · Employee Stock Option (right to buy) | +90,774 | 90,774 |
Page 2 of 10 · 196 trades